The function of the Emerging and High-Risk Pathogens (EHRP) core is to provide oversight and operational management of GNL BSL-4 facilities. The EHRP Core will be responsible for organization of the experimental work and procedures performed within the BSL-4 facility, training of personnel accessing BSL-4, management of infectious agent stocks stored in BSL-4, provision of service and field activities related to BSL-4 agents and management of waste generated in BSL-4. The EHRP Core will function in close association with the GNL Advanced Veterinary Services (GAVS) Core, Advanced Imaging Core (1C), GNL Insectory Laboratories Core (GIL), Advanced Technologies Core (ATC), the Collaborative Research Services (CRS) Core and several Facilities Cores. The work performed in GNL BSL-4 will play a major role for the preparedness and response against high-risk pathogens by advancing our understanding toward the basic mechanisms of pathogen biology and pathogenesis, and developing countermeasures such as vaccines, therapeutics and diagnostics. The EHRP Core represents a major focus of research activities in the GNL. The EHRP Core will serve as a training and working site for US-based and international scientists, technical personnel and pre- and postdoctoral fellows that require practical laboratory experience or who would like to pursue BSL-4 research, but do not have facilities available. In addition, the GNL BSL-4 will also serve as a training site for engineers, maintenance/operating personnel and biocontainment/ biosafety personnel to learn about the complex inner-workings of a BSL-4 laboratory. In this way, the EHRP Core will provide a unique combined training/teaching and research environment

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
National Biocontainment Laboratory Operation Cooperative Agreement (UC7)
Project #
5UC7AI070083-05
Application #
8080173
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
5
Fiscal Year
2010
Total Cost
$2,142,856
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Andersson, Jourdan A; Sha, Jian; Kirtley, Michelle L et al. (2018) Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics. Antimicrob Agents Chemother 62:
Beasley, David W C; Brasel, Trevor L; Comer, Jason E (2016) First vaccine approval under the FDA Animal Rule. NPJ Vaccines 1:16013
Sha, Jian; Kirtley, Michelle L; Klages, Curtis et al. (2016) A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates. Clin Vaccine Immunol 23:586-600
Fitts, Eric C; Andersson, Jourdan A; Kirtley, Michelle L et al. (2016) New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic Plague. mSphere 1:
Tiner, Bethany L; Sha, Jian; Cong, Yingzi et al. (2016) Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague. NPJ Vaccines 1:16020
Andersson, Jourdan A; Fitts, Eric C; Kirtley, Michelle L et al. (2016) New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Antimicrob Agents Chemother 60:3717-29
Ponnusamy, Duraisamy; Fitts, Eric C; Sha, Jian et al. (2015) High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection. Infect Immun 83:2065-81
Tiner, Bethany L; Sha, Jian; Kirtley, Michelle L et al. (2015) Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague. Infect Immun 83:1318-38
Rasmussen, Lynn; Tigabu, Bersabeh; White, E Lucile et al. (2015) Adapting high-throughput screening methods and assays for biocontainment laboratories. Assay Drug Dev Technol 13:44-54
Boisen, Matthew L; Schieffelin, John S; Goba, Augustine et al. (2015) Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. Viral Immunol 28:19-31

Showing the most recent 10 out of 43 publications